Public trial registry of the CCC-Munich

Trial 26866138MMY3022

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
26866138MMY3022
World
Full title
:

Randomisierte Phase-III-Studie zu Bortezomib und niedrig dosiertem Dexamethason mit oder ohne kontinuierliches niedrig dosiertes orales Cyclophosphamid bei primär refraktärem oder rezidiviertem multiplem Myelom

World
EudraCT number
:
2008-003213-27
World
NCT number
:
NCT00813150
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Indications
Classification Code Description
ICD-10-GM C90.0- Multiples Myelom
- Bloodcancer (leukemia, lymphoma)
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
III
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2013-01-31 / 2014-08-15
Participants
Function Prename Surname Organization
Printer
 
Application_get